A, D. V., L, S., V, F., N, G., E, P., C, F., . . . S, B. (2023). Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients. Panminerva medica, 65(3), 286. https://doi.org/10.23736/S0031-0808.22.04572-4
Chicago Style (17th ed.) CitationA, DE Vito, et al. "Early Treatment with Low-molecular-weight Heparin Reduces Mortality Rate in SARS-CoV-2 Patients." Panminerva Medica 65, no. 3 (2023): 286. https://doi.org/10.23736/S0031-0808.22.04572-4.
MLA (9th ed.) CitationA, DE Vito, et al. "Early Treatment with Low-molecular-weight Heparin Reduces Mortality Rate in SARS-CoV-2 Patients." Panminerva Medica, vol. 65, no. 3, 2023, p. 286, https://doi.org/10.23736/S0031-0808.22.04572-4.
Warning: These citations may not always be 100% accurate.